Whalen Wealth Management Inc. Neurocrine Biosciences Inc Transaction History
Whalen Wealth Management Inc.
- $144 Billion
- Q4 2024
A detailed history of Whalen Wealth Management Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Whalen Wealth Management Inc. holds 1,933 shares of NBIX stock, worth $213,789. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,933Holding current value
$213,789% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
95.2MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.57 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.12 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$541 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$334 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$281 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...